![]() | Up a level |
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K.; Papazova, Irina; Loehrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J.; Wehr, Michael C.; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M.; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Goerlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp; Falkai, Peter (2020): Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial. In: Contemporary Clinical Trials Communications, Vol. 17, 100537
Strassen, Ulrich; Greve, Jens; Stelter, Klaus; Havel, Miriam; Rotter, Nicole; Veit, Johannes; Schossow, Beate; Hapfelmeier, Alexander; Kehl, Victoria; Kojda, Georg; Hoffmann, Thomas K.; Bas, Murat (2016): A Randomized Trial of Icatibant in ACE-Inhibitor-Induced Angioedema. In: Journal of Allergy and Clinical Immunology, Vol. 137, No. 2: AB243-AB243